XPH ETF Holdings

Holdings

Symbol	Grade	Price % Change	Allocation
CORT	B	2.90	4.96
LBPH	A	0.05	4.12
BMY	B	1.10	4.11
ITCI	C	0.28	4.01
JAZZ	B	1.25	3.94
VTRS	A	0.91	3.73
AXSM	B	0.50	3.59
EWTX	C	0.69	3.42
CTLT	B	2.21	3.41
ELAN	D	-0.30	3.35
PRGO	B	3.66	3.35
RPRX	D	0.11	3.18
JNJ	D	-0.21	3.17
ZTS	D	0.14	3.15
PFE	D	2.07	3.07
LLY	F	-0.25	2.94
MRK	F	-0.68	2.93
TARS	B	3.97	2.81
OGN	D	2.62	2.58
SAVA	D	-17.71	2.57
ARVN	D	2.99	2.53
PBH	A	0.84	2.50
SUPN	C	1.12	2.15
AMPH	D	2.04	2.02
PCRX	C	0.98	1.91
LGND	B	2.27	1.77
ANIP	F	1.88	1.54
COLL	F	-1.48	1.48
OCUL	D	3.64	1.44
AMRX	C	0.84	1.33
MNMD	C	6.63	1.23
HRMY	D	2.53	1.22
WVE	C	-0.56	1.17
HROW	D	-2.23	1.17
INVA	D	0.47	0.98
EYPT	F	7.19	0.94
LQDA	D	4.93	0.89
PLRX	F	1.01	0.87
FULC	F	9.43	0.85
ELVN	D	-3.42	0.64
NUVB	C	3.70	0.60
EOLS	D	-3.37	0.52
PHAT	F	-1.16	0.48
XERS	B	1.64	0.46

Represented by ETF Holdings

Keywords: Biopharmaceutical Pharmaceutical Medicine Pharmaceutical Products Pain S&P 500 Alzheimer's Disease Animal Health Life Sciences Biotechnology Depression Diabetes Disease Drugs Hypertension Medication Neuroscience Pharmacology Suspension Acid

Industries: Biotechnology Drug Manufacturers - Specialty & Generic Drug Manufacturers - Major Drug Manufacturers - General Medical Distribution

Recent News for SPDR S&P Pharmaceuticals ETF & its Holdings

Date	Stock	Title
Nov 23	JNJ	Trump picks surgeon Marty Makary to head FDA, Rep. Dave Weldon to lead CDC
Nov 23	MRK	Trump picks surgeon Marty Makary to head FDA, Rep. Dave Weldon to lead CDC
Nov 22	LLY	Sanofi Plans to Change Hospital Drug-Discount Program
Nov 22	MRK	Merck recommends rejection of TRC Capital’s 'mini-tender' offer
Nov 22	MRK	Merck Recommends Rejection of TRC Capital’s "Mini-Tender" Offer
Nov 22	PFE	Pharma Stock Roundup: EU Nod for PFE's Hympavzi, NVS Ups Sales View
Nov 22	JNJ	Layoffs in 2024: A List of Companies Cutting Jobs This Year
Nov 22	PFE	BridgeBio heart drug approved by FDA, setting up battle with Pfizer
Nov 22	PFE	Novartis Raises Sales Outlook for Mid-Term, Acquires Kate Therapeutics
Nov 22	PFE	FDA Accepts Bayer's Application for Label Expansion of Nubeqa
Nov 22	CTLT	Catalent gains on reports it's likely to be granted EU approval for Novo Holdings deal (update)
Nov 22	PFE	Pfizer Inc. (PFE) Jefferies London Healthcare Conference (Transcript)
Nov 22	JNJ	J&J eyes FDA approval for injection-based Tremfya in ulcerative colitis
Nov 22	JNJ	Medtronic acquires Fortimedix Surgical to boost surgical portfolio
Nov 22	JNJ	Sanofi Plans to Change Hospital Drug-Discount Program
Nov 22	CORT	Corcept Shares Rise More Than 60% in Three Months: Here's Why
Nov 22	BMY	AbbVie Jumps Nearly 4% On An Upgrade Despite Bristol Myers-Tied Setback
Nov 22	PFE	Replimune Stock Rallies on BLA Filing for Melanoma Combo Drug
Nov 22	JNJ	Health Canada issues NOC to J&J’s CARVYKTI for multiple myeloma
Nov 22	MRK	Merck-marketed asthma drug linked to psychiatric issues: report

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a replication strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.
Exchange Traded Fund ETF Index Fund S&P Top 100 Loan Index Pharmaceuticals Segment

ETF Components for XPH - SPDR S&P Pharmaceuticals ETF